Leak resistant writing instrument

Details for Australian Patent Application No. 2003296423 (hide)

Owner BIC Corporation

Inventors Nowak, Michael T.; Thomas, Larry G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003296423

PCT Number PCT/US2003/0392

PCT Pub. Number WO2004/052659

Priority 10/315,659 10.12.02 US

Filing date 8 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 25 September 2008

International Classifications

B43K 5/18 (2006.01) Pens with ink reservoirs in holders, e.g. fountain-pens

B43K 7/08 (2006.01) Ball-point pens

B43K 7/10 (2006.01) Ball-point pens

B43K 8/04 (2006.01) Pens with writing-points other than nibs or balls

B43K 8/08 (2006.01) Pens with writing-points other than nibs or balls

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 10/315,659 10.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003296423

22 June 2006 Assignment before Grant

  BIC Corporation The application has been assigned to BIC Corporation

25 September 2008 Application Accepted

  Published as AU-B-2003296423

22 January 2009 Standard Patent Sealed

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003296424-NEUROTOXIC AMINO ACID OR NEUROTOXIC DERIVATIVE THEREOF ASSOCIATED WITH NEUROLOGICAL DISORDERS

2003296422-METHOD OF INHIBITING NEURAL TRANSMISSION MEDIATED BY SEROTONIN-2A AND ENHANCING SENSORIMOTOR GATING